- Advertisement -

Study shows the feasibility of using gene therapy to treat chronic traumatic encephalopathy

A new study shows the feasibility of using gene therapy to treat the progressive neurodegenerative disorder chronic traumatic encephalopathy (CTE). The study, which demonstrated...

African nations warm to crop biotechnology for potential food security gains – Genetic Literacy Project

Though only a few African countries are now growing genetically modified (GM) crops commercially, governments across the continent are increasingly recognizing the crucial role...

Sana Biotechnology Reports First Quarter 2021 Financial Results and Business Updates – GlobeNewswire

Presented key proof of concept data for multiple platforms at AACR 2021 Q1 2021 cash position of $981.9 million SEATTLE, May 05, 2021 (GLOBE...

Agilent Expands Cell Analysis Business with Planned $1.2B BioTek Acquisition

(L-R) Mike McMullen, president & CEO, Agilent Technologies; and Briar Alpert, president & CEO, BioTek Instruments. Agilent Technologies has signaled its intent to move...

Researchers unveil new methods for DNA mosaic recognition

As humans, we each have trillions of cells. And each cell has a nucleus with individual genetic information –DNA – that can mutate to...

Scientific Grand Prize awarded to renowned hearing loss researcher

M. Charles Liberman, PhD, whose research forever changed the way experts understand the underlying causes of hearing loss, has been awarded the Scientific Grand...

The Analytical Blueprint for Cell & Gene Therapy Success

Read NowCell and gene therapies have entered a new phase of maturity. Scientific innovation continues at an unprecedented pace, but so do the analytical...

Navigating the Regulatory Labyrinth: How Biotech Leaders Are Rethinking Strategy in...

There is a particular kind of anxiety that settles into a biotech boardroom when the regulatory environment becomes difficult to read. It is not...

The Analytical Blueprint for Cell & Gene Therapy Success

Read NowCell and gene therapies have entered a new phase of maturity. Scientific innovation continues at an unprecedented pace, but so do the analytical...

Navigating the Regulatory Labyrinth: How Biotech Leaders Are Rethinking Strategy in an Uncertain Regulatory...

There is a particular kind of anxiety that settles into a biotech boardroom when the regulatory environment becomes difficult to read. It is not...

TraceIQ Launched to Maximize Pharmaceutical Traceability

Systech launched TraceIQ, an intelligent, enterprise traceability platform designed to address the evolving operational aspects of pharmaceutical and biopharma supply chains. The first generation of...

more new items

The Analytical Blueprint for Cell & Gene Therapy Success

Read NowCell and gene therapies have entered a new phase of maturity. Scientific innovation continues at an unprecedented pace, but so do the analytical...

Navigating the Regulatory Labyrinth: How Biotech Leaders Are Rethinking Strategy in...

There is a particular kind of anxiety that settles into a biotech boardroom when the regulatory environment becomes difficult to read. It is not...

TraceIQ Launched to Maximize Pharmaceutical Traceability

Systech launched TraceIQ, an intelligent, enterprise traceability platform designed to address the evolving operational aspects of pharmaceutical and biopharma supply chains. The first generation of...